About the Study

If you take part in this study, the study doctor will see you monthly over the next 6 months to optimize your treatment, with the goal of reducing your gout attacks. This will help researchers to see how people respond to different doses of the gout medication allopurinol. About The Study Image

Text Size

About the study drug

Allopurinol is a currently approved and marketed drug for the long-term treatment of gout. Gout is caused by too much uric acid in your blood. Allopurinol works by stopping the body from producing too much uric acid, which eventually helps to reduce how often and how severely you suffer gout attacks. If you take part in this study, you will take a daily dose of allopurinol (at an optimum dose for you).

Because allopurinol may initially cause a gout attack, if you take part in this study you will also need to take daily medication to help prevent a gout attack.

Why this study is important

Sometimes allopurinol is prescribed to people at doses that are too low to effectively control their gout. This means that they may continue to have gout attacks, even if they are taking medication. This global interventional study will track the effectiveness and safety of individualized doses of allopurinol. The results of this study will help doctors to optimize treatment for people with gout.

If you qualify and consent to take part in this study, you will receive:

Close study-related monitoring of your gout to optimize your treatment at no cost to you
Compensation to cover your time and travel expenses
Reimbursement for your gout medication (allopurinol)

to find out if you may qualify to take part in this clinical research study.

Take control of your gout.

Whether your gout is currently on the attack or in hiding,

About the Study

About the study drug

Why this study is important

If you qualify and consent to take part in this study, you will receive: